Search
for
Sort by
Research 511–540 of 1000+
- Hidradenitis Suppurativa
- How to Diagnose Hair Loss
- Effect of finasteride in idiopathic hirsutism
- Androgen antagonists in androgen target tissues
- Post-finasteride syndrome: An emerging clinical problem
- Congenital adrenal hyperplasia
- Stem cells and aberrant signaling of molecular systems in skin aging
- A missing piece: the spiny mouse and the puzzle of menstruating species
- Alterations in androgen conjugate levels in women and men with alopecia
- Clinical markers of androgenicity in acne vulgaris
- Androgen receptor modulators: a review of recent patents and reports (2012-2018)
- The Modified Ferriman-Gallwey Score and Hirsutism among Filipino Women
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- The Aging Face
- Chromium supplementation in women with polycystic ovary syndrome: Systematic review and meta-analysis
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Getting under the skin of hair aging: the impact of the hair follicle environment
- Female Adolescent Hair Disorders
- HAIR MATRIX CELL KINETICS: A SELECTIVE REVIEW
- Assessment, diagnosis and treatment of a patient with hirsutism
- Impact of Treatment with Rosiglitazone or Metformin on Biomarkers for Insulin Resistance and Metabolic Syndrome in Patients with Polycystic Ovary Syndrome
- CLINICAL UPDATES IN HAIR
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- Characterization of metabolic changes in the phenotypes of women with polycystic ovary syndrome in a large Mediterranean population from Sicily
- Skin and glucocorticoids: effects of local skin glucocorticoid impairment on skin homeostasis
- Genetic basis of polycystic ovary syndrome
- Chapter 17. Selective androgen receptor modulators (SARMs)
- Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome
- No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours
- Selenium and Polycystic Ovary Syndrome; Current Knowledge and Future Directions: A Systematic Review